Does Smoking Increase Carbon Dioxide in the Blood?

Smoking does increase carbon dioxide levels in the blood, though the pathway is more complex than simply breathing in CO2-rich smoke. Cigarette smoke itself contains carbon dioxide at roughly 200 times the concentration found in normal air, but the bigger and more lasting effect comes from the progressive damage smoking inflicts on the lungs’ ability to expel CO2 with each breath. Over months and years, this impaired gas exchange can tip the balance toward chronically elevated blood CO2, a condition known as hypercapnia, which carries its own cascade of health consequences.

What You Inhale With Each Puff

Cigarette smoke is a cocktail of thousands of chemicals, and carbon dioxide is one of the most abundant. Researchers investigating the inflammatory effects of tobacco smoke noted that CO2 in mainstream cigarette smoke sits at a concentration roughly 200 times higher than what you normally breathe in from the surrounding air.¹ That alone might sound alarming, but the volume of each puff is small, so the direct CO2 load from a single cigarette is brief. Your body can handle short bursts of elevated CO2 without lasting blood-level changes, provided your lungs are healthy enough to clear it quickly. The real danger is not the CO2 you inhale in the moment but the structural harm smoking does to the machinery responsible for getting CO2 out of your blood on an ongoing basis.

How Lungs Normally Clear Carbon Dioxide

Your lungs work as a gas-exchange surface. Oxygen passes from the air sacs into your blood, and CO2 moves the other direction, from your blood into the air you exhale. This happens across a thin membrane in millions of tiny sacs called alveoli, and the efficiency of the transfer depends on two things working together: adequate airflow reaching the alveoli (ventilation) and adequate blood flow running past them (perfusion). When ventilation and perfusion are well matched throughout the lungs, CO2 leaves the blood efficiently and oxygen enters smoothly.

Smoking disrupts this balance on both sides. Inhaled toxins directly damage the alveolar walls, reducing the surface area available for gas exchange. At the same time, inflammation narrows airways and alters blood flow patterns, creating regions of the lung where air and blood are mismatched. A large retrospective study of over 30,000 subjects found that cigarette smoke exposure caused significant declines in the lungs’ diffusing capacity, with direct alveolar toxicity and ventilation-perfusion mismatch both contributing to the impairment.² In practical terms, oxygen uptake becomes harder, and CO2 clearance slows down.

Reduced Diffusing Capacity and CO2 Buildup

Clinicians measure how well your lungs transfer gases using a test called DLCO, which reflects the overall efficiency of gas diffusion across the lung membrane. Smokers consistently score lower on this test, even those who have not yet developed obvious airflow obstruction. A population-based study found that the lower DLCO in smokers reflects greater ventilation-perfusion inequalities, reduced carbon dioxide elimination efficiency, and consequently greater stimulation of the respiratory drive, which helps explain why many smokers feel short of breath even before receiving a formal diagnosis of lung disease.³ The body tries to compensate by breathing faster and harder, but this only partially offsets the underlying problem. CO2 that should be leaving the blood efficiently begins lingering, nudging levels upward.

This matters because your body’s CO2 level is not just a waste-product reading. Blood CO2 directly affects blood pH, and even modest chronic elevations shift the acid-base balance in ways that affect organ function, mental clarity, and the responsiveness of the respiratory center in the brainstem. A healthy body holds arterial CO2 within a fairly narrow range, and the early stages of smoking-related lung damage often keep CO2 in the normal zone only because the body works harder to compensate. When that compensation fails, overt hypercapnia follows.

Chronic Hypercapnia and COPD

Chronic obstructive pulmonary disease is the endpoint where smoking-related CO2 retention becomes most clinically obvious. In COPD, the alveolar destruction (emphysema) and airway narrowing (chronic bronchitis) become severe enough that the lungs simply cannot expel CO2 at the rate the body produces it. Research using animal models of cigarette smoke-induced emphysema demonstrated that prolonged smoke exposure produced not only structural lung damage and inflammation but also measurable hypercapnia and hypoxemia, meaning both elevated CO2 and reduced oxygen in the blood.⁴

One of the most concerning findings from that same work was a blunted ventilatory response: the emphysematous animals lost the normal reflex to breathe harder when CO2 rose or oxygen dropped. This mirrors what clinicians see in advanced COPD patients, whose brainstems gradually reset to tolerate higher CO2 levels as the new baseline. For these patients, the usual alarm system that triggers deeper or faster breathing when CO2 climbs becomes dulled. The result is a vicious cycle where CO2 keeps rising, but the body’s compensatory drive to breathe it off weakens.⁴

Not every smoker develops COPD, and not every COPD patient becomes hypercapnic. But chronic CO2 retention is far more common among people with a smoking history than among nonsmokers, and it tends to appear in the later stages of disease when lung damage is extensive. By that point, treatment options are limited mostly to supplemental oxygen, ventilatory support, and smoking cessation to prevent further deterioration.

Carbon Dioxide Versus Carbon Monoxide

A frequent point of confusion is the difference between carbon dioxide (CO2) and carbon monoxide (CO), both of which are present in cigarette smoke. CO tends to get more attention in clinical discussions because of its well-known ability to bind tightly to hemoglobin, displacing oxygen. Research on Sri Lankan adult smokers found that smokers had significantly higher exhaled carbon monoxide levels and blood carboxyhemoglobin concentrations compared to nonsmokers, confirming that CO from smoke binds efficiently to hemoglobin in the bloodstream.⁵

CO and CO2 have different mechanisms of harm. Carbon monoxide’s main threat is that it hogs the spots on hemoglobin where oxygen should attach, so even though your lungs might pull in enough oxygen, less of it actually reaches your tissues. Carbon dioxide’s threat is more about accumulation: when the lungs cannot clear it efficiently, it builds up in the blood and shifts your acid-base balance. In a smoker, both processes happen simultaneously. CO directly reduces oxygen delivery, while impaired CO2 clearance acidifies the blood and stresses the cardiovascular system. The two problems compound each other, which is part of why smoking carries such outsized cardiovascular risk.

Secondhand Smoke and CO2

The effects are not limited to the person holding the cigarette. A study measuring physiological responses during exercise found that passive inhalation of sidestream cigarette smoke significantly elevated CO2 output, raised heart rate, and increased perceived effort compared to exercising in clean air.⁶ The CO2 output measured in the study increased from about 1.58 to 1.68 liters per minute, a meaningful jump during submaximal exercise.⁶

This rise likely reflects a combination of inhaling the CO2-laden sidestream smoke and the body’s metabolic response to the irritants and CO within it. When CO takes up hemoglobin binding sites, your cardiovascular system compensates by working harder, which increases metabolic CO2 production as a byproduct. So secondhand smoke does not just deliver CO2 directly; it also forces your body to generate more of it. For people who exercise near smokers or spend time in poorly ventilated smoky environments, the added CO2 burden on top of the oxygen reduction adds up to a noticeable decline in exercise tolerance.

Why Smokers Are Harder to Monitor During Surgery

One practical consequence of smoking-related CO2 changes surfaces in the operating room. Anesthesiologists routinely monitor end-tidal CO2, which is the CO2 concentration in the last bit of exhaled air, as a proxy for arterial CO2. In most patients, these two measurements track closely. But in smokers, the gap between arterial and end-tidal CO2 widens, making end-tidal readings a less reliable indicator of what is actually happening in the blood.⁷ The reason loops back to the ventilation-perfusion mismatch described earlier: when parts of the lung are poorly perfused or poorly ventilated, the exhaled gas does not accurately represent the blood’s gas composition.

This means that during surgery, a smoker’s blood CO2 could be climbing into dangerous territory while the monitor on the breathing circuit still shows a reassuring number. Anesthesia teams account for this by drawing arterial blood gases more frequently in patients with smoking histories, but it adds a layer of complexity and risk that nonsmokers do not present. It is one of the reasons surgical teams strongly recommend quitting even a few weeks before a planned procedure, since some of the acute inflammatory and gas-exchange effects of smoking begin to improve within days to weeks of the last cigarette.

Maternal Smoking and Infant Breathing Reflexes

Smoking during pregnancy affects more than the mother’s own CO2 balance. A study of small-for-gestational-age infants examined how the babies’ breathing responded to mild increases in CO2 and decreases in oxygen. Among these undersized newborns, those whose mothers smoked during pregnancy had a significantly stronger ventilatory response to the test gases: their breathing rate climbed by roughly eight breaths per minute under the combined CO2 and low-oxygen challenge, compared to about four breaths per minute in infants of nonsmoking mothers.⁸ Their minute ventilation increased by about 141% versus 119% in the nonsmoker group.⁸

At first glance, a stronger breathing response sounds protective, but the picture is more nuanced. An exaggerated response to CO2 reflects a brainstem that has been calibrated differently, and the concern is that this altered calibration may be unstable. Some researchers believe that prenatal smoke exposure changes the set points in the infant’s respiratory control centers, and that while the initial response may be heightened, the long-term risk of unstable breathing patterns, particularly during sleep, could increase. This is part of the broader body of research linking maternal smoking to elevated risk of sudden infant death.

How Marijuana Smoke Compares

People sometimes wonder whether the CO2 effects of smoking apply equally to other types of smoke. A study looking at marijuana smoke of varying potencies found no significant changes in ventilatory responses to either elevated CO2 or low oxygen, and no changes in resting CO2 output or oxygen consumption in habitual marijuana smokers.⁹ The researchers concluded that smoking marijuana at the doses tested had no acute effect on central or peripheral ventilatory drive or metabolic rate.

This does not mean marijuana smoke is harmless to the lungs; it contains many of the same irritants and particulates found in tobacco smoke. But the specific CO2-related disruptions appear to be much less pronounced. One possible explanation is the sheer difference in exposure volume. A typical cigarette smoker inhales far more total smoke over a day than even a heavy marijuana user, and the chronic, repetitive nature of tobacco use is what drives the progressive alveolar damage that eventually impairs CO2 clearance. A few joints a week simply do not deliver the same cumulative insult to the gas-exchange surface.

What Happens When You Quit

The timeline for CO2-related recovery after quitting depends heavily on how much damage has already accumulated. Some improvements begin almost immediately. Carbon monoxide clears the bloodstream within 24 to 72 hours, freeing hemoglobin to carry oxygen again, which reduces the metabolic strain that drives excess CO2 production. Airway inflammation starts to calm within weeks, and mucociliary clearance, the self-cleaning mechanism of the airways, begins to recover over the first few months.

Gas exchange efficiency takes longer. The ventilation-perfusion mismatch that smoking creates can improve partially as inflammation resolves, but structural destruction of alveoli in emphysema is permanent with current medical treatments. A smoker who quits before developing significant emphysema may see their CO2 clearance return to near-normal over months to a year. A smoker who has already lost substantial alveolar surface area will not get that tissue back, but quitting still slows the rate of further loss and helps stabilize whatever gas-exchange capacity remains.

For surgical planning, even short-term cessation matters. The wider arterial-to-end-tidal CO2 gap that complicates anesthesia monitoring begins to narrow within weeks of quitting as acute airway inflammation subsides.⁷ This is why many surgeons push for at least four to eight weeks of abstinence before elective procedures. The lungs may not fully heal in that window, but the acute monitoring challenges become more manageable.

The Inflammation Angle

An underappreciated part of the CO2 story is that the carbon dioxide in cigarette smoke may itself be an inflammatory trigger, independent of the other toxins. The same study that documented the 200-fold CO2 concentration in mainstream smoke was specifically investigating whether CO2 was responsible for some of the acute inflammatory effects of tobacco smoke inhalation.¹ The findings suggested that CO2, often dismissed as a benign byproduct, plays a more active role in the inflammatory cascade than previously thought.

If confirmed by further work, this adds another layer to the problem. Chronic airway inflammation is what drives the progressive tissue remodeling and destruction that eventually makes CO2 clearance impossible in advanced COPD. If the CO2 in each puff of smoke contributes to that inflammation, it creates a feedback loop: smoke delivers CO2 that inflames the airways, the inflamed airways become less efficient at clearing CO2, and the retained CO2 may contribute to further tissue damage. It is an area where the science is still developing, but it reframes CO2 from a passive indicator of lung health to a potential active participant in smoking-related disease.